Valuation : AstraZeneca PLC

Market Cap 25TCr 1,29100Cr 22TCr 20TCr 19TCr 35TCr 23,81200Cr 35TCr 2,41500Cr 93TCr 12,19400Cr 95TCr 92TCr 38,84300Cr P/E 2026 *
20.9x
P/E 2027 * 18.3x
Enterprise Value 27TCr 1,39100Cr 23TCr 22TCr 20TCr 37TCr 25,65300Cr 38TCr 2,60100Cr 1,00600Cr 13,13700Cr 1,01900Cr 1LCr 41,84500Cr EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.94x
Free-Float
96.63%
Yield 2026 *
2.06%
Yield 2027 * 2.19%
1 day-0.24%
1 week-1.05%
Current month-0.80%
1 month+1.62%
3 months-12.80%
6 months-18.39%
Current year-17.34%
1 week 137.21
Extreme 137.21
141.39
1 month 133.75
Extreme 133.75
145.6
Current year 130.06
Extreme 130.06
190.4
1 year 130.02
Extreme 130.02
190.4
3 years 101.6
Extreme 101.6
190.4
5 years 93.74
Extreme 93.74
190.4
10 years 93.74
Extreme 93.74
190.4
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-1.05% - - 25TCr
-0.88%-2.15%+58.05%+105.26% 1,02400Cr
-1.15%+2.68%+54.25%+74.19% 66TCr
-1.44%+0.38%+20.65%+76.13% 45TCr
-0.95%+0.23%+30.91%+37.78% 35TCr
-3.18%+1.78%+22.62%+41.55% 30TCr
+0.30%+0.67%+0.60%+11.25% 25TCr
-1.55%+1.11%+54.15%+75.59% 24TCr
+0.02%+2.24%-13.83%-55.80% 21TCr
-0.15%+3.65%+31.24%+103.39% 19TCr
Average -0.90%+1.26%+28.74%+52.15% 40.87TCr
Weighted average by Cap. -0.99%+0.62%+37.66%+66.90%

Financials

2026 *2027 *
Net sales 6.33TCr 32TCr 5.44TCr 5.12TCr 4.67TCr 8.74TCr 5,98500Cr 8.77TCr 61TCr 23TCr 3,06500Cr 24TCr 23TCr 9,76200Cr 6.69TCr 34TCr 5.75TCr 5.41TCr 4.94TCr 9.23TCr 6,32400Cr 9.26TCr 64TCr 25TCr 3,23800Cr 25TCr 25TCr 10,31500Cr
Net income 1.2TCr 6.16TCr 1.03TCr 972.08Cr 887.37Cr 1.66TCr 1,13700Cr 1.66TCr 12TCr 4.46TCr 58TCr 4.51TCr 4.41TCr 1,85400Cr 1.37TCr 7.02TCr 1.18TCr 1.11TCr 1.01TCr 1.89TCr 1,29600Cr 1.9TCr 13TCr 5.08TCr 66TCr 5.15TCr 5.03TCr 2,11400Cr
Net Debt 1.95TCr 9.98TCr 1.67TCr 1.57TCr 1.44TCr 2.69TCr 1,84100Cr 2.7TCr 19TCr 7.21TCr 94TCr 7.31TCr 7.15TCr 3,00200Cr 1.18TCr 6.04TCr 1.01TCr 953.51Cr 870.42Cr 1.63TCr 1,11500Cr 1.63TCr 11TCr 4.37TCr 57TCr 4.43TCr 4.33TCr 1,81900Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
04/26/04 R$139.42 -0.24% 2,553
03/26/03 R$139.76 +1.32% 7,311
02/26/02 R$137.94 -1.33% 124
01/26/01 R$139.80 -0.53% 26
31/26/31 R$140.55 -0.25% 120
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
162.34USD
Average target price
212.94USD
Spread / Average Target
+31.17%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!